May Contain: Titanium Dioxide (CI 77891), Iron Oxides (CI 77491), Iron Oxides (CI 77492), Iron Oxides (CI 77499), Bismuth Oxychloride (CI 77163), Blue 1 Lake (CI 42090), Carmine (CI 75470), Manganese Violet (CI 77742), Red 6 (CI 15850), Red 7 (CI 15850), Red 21 (CI 45380), Red 30 (CI 73360), Red 7 Lake (CI 15850), Red 28 Lake (CI 45410), Red 30 Lake (CI 73360), Yellow 5 Lake (CI 19140), Yellow 6 Lake (CI 15985)
Initially, employed for the treatment of early-stage head and neck cancers, SSND is presently used in the management of lateral cervical siLNs of PTC (101, 102)
The Technology Foresights model emerges as a valuable tool for evaluating potential targets in this evolving landscape.
Channel fragmentation will likely persist: insured patients may stay with traditional pharmacies to capture benefits, while under-insured or privacy-seeking consumers gravitate toward digital platforms